Clinical Trials Directory

Trials / Completed

CompletedNCT03918200

Serum Amyloid A in Women With Unexplained Infertility

Serum Amyloid A Level in Women With Unexplained Infertility

Status
Completed
Phase
Study type
Observational
Enrollment
90 (actual)
Sponsor
Ain Shams Maternity Hospital · Academic / Other
Sex
Female
Age
40 Years
Healthy volunteers
Accepted

Summary

High follicular fluid amyloid A level is associated with reduced pregnancy rate. The aim of this study was to find an association between serum level of amyloid A and unexplained infertility.

Conditions

Interventions

TypeNameDescription
OTHERSerum amyloid A levelFor determination of SAA level, a 5-ml sample of venous blood will be taken from each participant under aseptic conditions, and centrifuged at 2500 g for 15 minutes at 4°C c. separated into serum aliquots,and stored frozen at -80°C until analysis of SAA ,which will be done by a double-antibody sandwich Enzyme Linked Immunosorbent Assay (ELISA) kits supplied by cusabio,USA according to manufacturers instruction .Each sample was tested in duplicate and the average will be taken. A cut off level of 30 mg/L SAA level will be chosen to reflect a real increase in its level

Timeline

Start date
2018-10-01
Primary completion
2019-03-10
Completion
2019-03-10
First posted
2019-04-17
Last updated
2019-04-17

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03918200. Inclusion in this directory is not an endorsement.

Serum Amyloid A in Women With Unexplained Infertility (NCT03918200) · Clinical Trials Directory